Novan (NOVNW) EPS (Diluted) : $0.00 (TTM As of Mar. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Novan EPS (Diluted)?

Novan's Earnings per Share (Diluted) for the three months ended in Mar. 2023 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00.

Novan's EPS (Basic) for the three months ended in Mar. 2023 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00.

Novan's EPS without NRI for the three months ended in Mar. 2023 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00.

During the past 3 years, the average EPS without NRIGrowth Rate was 47.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 43.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, Novan's highest 3-Year average EPS without NRI Growth Rate was 51.90% per year. The lowest was -27.10% per year. And the median was 46.75% per year.

Novan EPS (Diluted) Historical Data

The historical data trend for Novan's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novan EPS (Diluted) Chart

Novan Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EPS (Diluted)

Get a 7-Day Free Trial

Novan Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
EPS (Diluted)	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Novan's EPS (Diluted)

For the Biotechnology subindustry, Novan's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novan's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Novan's PE Ratio distribution charts can be found below:

* The bar in red indicates where Novan's PE Ratio falls into.

Novan EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Novan's Diluted EPS for the fiscal year that ended in Dec. 2022 is calculated as

Diluted EPS (A: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-31.311	-	0)	/	0
	=

Novan's Diluted EPS for the quarter that ended in Mar. 2023 is calculated as

Diluted EPS (Q: Mar. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-14.119	-	0)	/	0
	=

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

Novan (OTCPK:NOVNW) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Novan EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Novan's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Novan Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novan Inc (OTCPK:NOVNW) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

P.O. Box 64, Pittsboro, NC, USA, 27312

Website

https://www.novan.com

NVN Liquidation Inc Formerly Novan Inc is a dermatology company focused on developing and commercializing therapeutic products for skin diseases. It is developing SB206 as a topical prescription gel for the treatment of viral skin infections. The company's product portfolio includes; Wynzora Cream for the treatment of plaque psoriasis, Rhofade cream for the treatment of persistent facial erythema, Minolira tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients, Cloderm cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, Sitavig tablets for the treatment of recurrent herpes labialis in immunocompetent adults, and Nuvail nail solution for managing signs and symptoms of nail dystrophy.